Skip to main content
. 2007 Sep 19;14(11):1451–1457. doi: 10.1128/CVI.00195-07

TABLE 1.

MenB P1.19,15 wild-type isolates investigated in the SBA assay

Isolate Phenotype Immunotype Sequence type Clonal complex Isolation sitea Date of isolation (day/mo/yr) Geographical location
M00 242888 B:4:P1.19,15 L3,7,9 749 32 Nasal swab 31/10/2000 Malta
M00 243202 B:4:P1.19,15 L3,7,9 34 32 CSF 11/12/2000 Rochdale, United Kingdom
M01 240075 B:4:P1.19,15 L3,7,9 749 32 CSF 06/01/2001 North Tyneside, United Kingdom
M01 240121 B:4:P1.19,15 L3,7,9 1398 32 Blood 09/01/2001 Milton Keynes, United Kingdom
M01 240265 B:4:P1.19,15 L3,7,9 749 32 Blood 25/01/2001 Malta
M01 240400 B:4:P1.19,15 L3,7,9 749 32 Blood 07/02/2001 Malta
M01 241017 B:4:P1.19,15 L3,7,9 41 41/44 Blood 10/04/2001 Nottingham, United Kingdom
M01 241117 B:4:P1.19,15 L3,7,9 749 32 Blood 27/04/2001 Malta
M01 241535 B:4:P1.19,15 L3,7,9 749 32 CSF 28/06/2001 Liverpool, United Kingdom
a

CSF, cerebrospinal fluid.